Childhood Leukemia, Lymphoma, and Histiocytosis

The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top pediatric leukemia and lymphoma treatment centers in the world. In addition to treating blood cancers — leukemias and lymphomas — our center treats the primary types of histiocytosis, which is not a form of cancer but shares some of the characteristics of cancer and is often treated using some of the same therapies. We treat these conditions:

Leukemia

• Acute lymphoblastic leukemia (ALL), including relapsed acute lymphobastic leukemia
• Acute myeloid leukemia (AML)
• Chronic myeloid leukemia (CML)
• Juvenile myelomonocytic leukemia

— Learn about our Pediatric Leukemia Treatment Program.

Lymphoma

• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Burkitt’s lymphoma
• Large cell lymphoma
• Lymphoblastic lymphoma
• Lymphoma of bone

— Learn about our Pediatric Lymphoma Treatment Program. 

Histiocytosis

• Langerhans cell histiocytosis
• Hemophagocytic lymphohistiocytosis

— Learn about our Pediatric Histiocytosis Treatment Program.

— Learn about our Node Assessment Program.